Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

PRINCETON BIOMEDITECH CORP.

United States·US-MF-000048310

Last updated September 17, 2026

What PRINCETON BIOMEDITECH CORP. makes

Princeton Biomeditech Corp. manufactures in vitro diagnostic (IVD) test kits for rapid immunochromatographic detection of substances and biomarkers in clinical settings. These include kits for cocaine and cocaine metabolites, cannabinoids and cannabinoid metabolites, opiates and opiate metabolites, total human chorionic gonadotropin (hCG), phencyclidine (PCP), methamphetamine, amphetamine, and beta-haemolytic Group A Streptococcus antigen.

The company's devices are classified as Class I, Class II, IVD General, N, and U, and are listed in regulatory databases including EUDAMED, FDA 510(k), and FDA UDI. Princeton Biomeditech Corp. is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What does Princeton Biomeditech Corp. manufacture?

Princeton Biomeditech Corp. manufactures in vitro diagnostic (IVD) test kits for rapid immunochromatographic detection of substances and biomarkers in clinical settings, including kits for cocaine and cocaine metabolites, cannabinoids and cannabinoid metabolites, opiates and opiate metabolites, total human chorionic gonadotropin (hCG), phencyclidine (PCP), methamphetamine, amphetamine, and beta-haemolytic Group A Streptococcus antigen.

Where is Princeton Biomeditech Corp. based?

Princeton Biomeditech Corp. is based in the United States, as stated in the provided device data under the COUNTRY field.

Which regulatory registries list devices from Princeton Biomeditech Corp.?

Devices from Princeton Biomeditech Corp. are listed in EUDAMED, FDA 510(k), and FDA UDI, as specified in the LISTED IN field of the device data.

How are the devices from Princeton Biomeditech Corp. classified?

The devices from Princeton Biomeditech Corp. are classified as Class I, Class II, IVD General, N, and U, according to the DEVICE CLASSES field in the provided data.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
United States
Address
4242 , US Highway 1, Monmouth Junction, United States
Website
www.pbmc.com
LinkedIn
—
Facebook
—
Phone
+1 732-274-1000
PRRC Contact
Young-A Kim
EUDAMED SRN
US-MF-000048310
FDA FEI Number
2246703
DUNS Number
—

Catalogue (213)

Page 1 of 5
DeviceModel / ReferenceRegistriesClassStatus
Accusay Mono ACC-M001P
EUDAMED
IVD GeneralActive
AccuSign® MET card DOA-202-35-02
FDA UDI
Class IIActive
StatusFirst™ hCG S/U card BSP-122-35-02
FDA UDI
Class IIActive
LifeSign® MI Troponin I card LSC-130-20-00
FDA UDI
Class IIActive
LifeSign® MI CK-MB/Myo/TnI card LSC-300-20-00
FDA UDI
Class IIActive
Status DS™ 4/MET stick DOA-141-10-00
FDA UDI
Class IIActive
Status Flu A+B Nasal Wash/Aspirate Kit BSP-510AS-04
FDA UDI
Class IActive
Status™ H. pylori card BSP-406WB-25-02
FDA UDI
Class IActive
Status AccuStrep A card BSP-181-25-01
FDA UDI
Class IActive
Status DS™ 4/MET stick DOA-141-35-00
FDA UDI
Class IIActive
Status hCG card BSP-121-35-01
FDA UDI
Class IIActive
Status Flu A & B BSP-510-05-00
FDA UDI
Class IActive
Status™ COVID-19 Antigen Rapid Test for Home Use BSP-512-25-00
FDA UDI
NActive
BioStrep® A BSP-185-30-04
FDA UDI
Class IActive
OvuSign® LH card OSH-143-35-01
EUDAMEDFDA UDI
Class IActive
BioSign® hCG card BSP-121-35-07
FDA UDI
Class IIActive
AccuSign® COC card DOA-200-10-02
FDA UDI
Class IIActive
LifeSign® MI StatusFirst CK-MB/Myo/TnI card LSC-300-01-00
FDA UDI
Class IIActive
AccuSign® DOA 8 card DOA-280-25-04
FDA UDI
UActive
Status DS™ 9 card DOA-290-25-01
FDA UDI
Class IIActive
Status DS™ TCA card DOA-209-35-01
FDA UDI
Class IIActive
Status Strep A Plus BSP-185-50-01
FDA UDI
Class IActive
Status Flu A+B card BSP-510-22-01
FDA UDI
Class IActive
Status hCG card BSP-121-12-00
FDA UDI
Class IIActive
AccuSign® DOA 2 THC/COC card DOA-221-35-02
FDA UDI
Class IIActive
AccuSign® TCA card DOA-209-35-02
FDA UDI
Class IIActive
BioSign® Strep A card BSP-181-25-02
FDA UDI
Class IActive
Status DS™ 9 card DOA-290-10-01
FDA UDI
Class IIActive
Status Stick™ 5/MET Stick DOA-151-35-00
FDA UDI
Class IIActive
AccuSign® MET card DOA-202-10-02
FDA UDI
Class IIActive
AccuSign® DOA 4/MET card DOA-241-35-02
FDA UDI
Class IIActive
Status Strep A Flip BSP-182-25-00
FDA UDI
Class IActive
Status™ hCG S/U card BSP-120S-12-00
FDA UDI
Class IIActive
Status Strep A Flip BSP-182-12-00
FDA UDI
Class IActive
BioSign® RC hCG S/U card BSP-122-35-01
FDA UDI
Class IIActive
BioSign® Mono card BSP-402WB-35-01
FDA UDI
Class IIActive
Status Strep A Plus BSP-185-05-00
FDA UDI
Class IActive
AccuSign® MTD card DOA-208-35-02
FDA UDI
Class IIActive
PBM Cardiac Marker Control LSC-300C-01
FDA UDI
N/AActive
Status™ H. pylori card BSP-406WB-30-07
FDA UDI
Class IActive
AccuSign® DOA 2 THC/COC card DOA-221-10-02
FDA UDI
Class IIActive
AccuSign® OPI card DOA-203-10-02
FDA UDI
Class IIActive
Status Mono Waived card BSP-402WB-10-03
FDA UDI
Class IIActive
Status DS™ 10 card DOA-300-10-01
FDA UDI
Class IIActive
AccuSign® DOA 4/AMP card DOA-240-35-02
FDA UDI
Class IIActive
Status DS™ 8 card DOA-280-25-01
FDA UDI
Class IIActive
Status™ COVID-19 Antigen Rapid Test for Home Use BSP-512-02-00
FDA UDI
NActive
AccuSign® DOA 5/AMP card DOA-250-35-02
FDA UDI
UActive
Status iFOBT Mailers with Collection Tubes Kit BSP-300-TM-01
FDA UDI
N/AActive
Status™ hCG strip BXI-113-35-00
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (4)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

There are 4 recall records for Princeton Biomeditech Corp., with the earliest initiated on 2012-03-09 and the most recent on 2024-08-23. The statuses of these recalls include open, classified, and terminated. The reasons given for the recalls include customer complaints of false negative hCG test results when running patient urine samples, and reports of dual positive (Flu A + Flu B positive) results being encountered.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Aug 23, 2024Z-0259-2025—open, classified

This recall was initiated due to customer complaints of false negative of hCG test results when running patient urine samples. Use of the above listed product lot may result in false negative results. An end user reported that the OSOM Ultra hCG Combo Test, lot 563L13, produced false negative test results from 2 patient urine samples as confirmed by quantitative hCG and ultrasound. During further root cause testing and investigation, an additional 6 devices were found to produce false negative test results from hCG positive samples.

Mar 9, 2012Z-2306-2012—terminated

There have been reports of dual positive (Flu A + Flu B positive) results being encountered.

Mar 9, 2012Z-2307-2012—terminated

There have been reports of dual positive (Flu A + Flu B positive) results being encountered.

Mar 9, 2012Z-2308-2012—terminated

There have been reports of dual positive (Flu A + Flu B positive) results being encountered.